The goal of this clinical trial is to investigate whether robot-assisted laparoscopic partial nephrectomy by extraperitoneal approach in the prone position had any advantages over the traditional lateral position. The main questions it aims to answer are: Is prone surgery safe and feasible, and what are the advantages over the traditional lateral position? Does surgery in the prone position have an impact on the patients\' prognosis? Researchers will compare prone position to lateral position to see if robot-assisted laparoscopic partial nephrectomy by extraperitoneal approach in the prone position has any advantages over the traditional lateral position and whether it has any significant effect on the prognosis of the patients. Participants will be randomly allocated 1:1 to two groups: prone position group and lateral position group. The enrolled patients will be underwent robotic-assisted laparoscopic partial nephrectomy via extraperitoneal approach according to the corresponding positions of their groups. Demographic indicators and perioperative-related indicators will be counted and recorded. CT or MRI and related biochemical examinations will be reviewed at 1 month, 3 months, 6 months and 1 year after surgery, and every 1 year thereafter. The similarities and differences of the indicators in different positions will be analysed, and subgroup analyses will be performed according to the corresponding results.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
This group of patients underwent robotic-assisted laparoscopic partial nephrectomy via extraperitoneal approach in the prone position
This group of patients underwent robotic-assisted laparoscopic partial nephrectomy via extraperitoneal approach in the lateral position
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
RECRUITINGTumour characteristics checklist
We will record tumor size (cm), location, position, laterality through preoperative imaging.
Time frame: Baseline ( before surgery)
Tumour characteristics assessed by RENAL nephrometry score
The R.E.N.A.L. Nephrometry Score consists of (R)adius (tumor size as maximal diameter), (E)xophytic/endophytic properties of the tumor, (N)earness of tumor deepest portion to the collecting system or sinus, (A)nterior (a)/posterior (p) descriptor and the (L)ocation relative to the polar line. The suffix h (hilar) is assigned to tumors that abut the main renal artery or vein. Of the 5 components 4 are scored on a 1, 2 or 3-point scale with the 5th indicating the anterior or posterior location of the mass relative to the coronal plane of the kidney. Higher scores indicate more complex tumour.
Time frame: Baseline ( before surgery)
Demographics of patients
age (year)
Time frame: Baseline ( before surgery)
Demographics of patients
gender
Time frame: Baseline ( before surgery)
Demographics of patients
BMI (kg/m2)
Time frame: Baseline ( before surgery)
Demographics of patients
American Society of Anesthesiology score
Time frame: Baseline ( before surgery)
Demographics of patients
age-adjusted charlson comorbidity index
Time frame: Baseline ( before surgery)
Demographics of patients
preoperative estimated glomerular filtration rate(ml/min/1.73m2).
Time frame: Baseline ( before surgery)
Perioperative data
intraoperative average PaCO2(mmHg).
Time frame: Intraoperative status
Perioperative data
operation time(minute)
Time frame: Intraoperative status
Perioperative data
hilar access time(minute)
Time frame: Intraoperative status
Perioperative data
warm ischemia time(minute).
Time frame: Intraoperative status
Perioperative data
suturing time(minute).
Time frame: Intraoperative status
Perioperative data
estimated blood loss(ml).
Time frame: Intraoperative status
Perioperative data
transfusion rate(%)
Time frame: Intraoperative status
Perioperative data
rate of positive surgical margin(%)
Time frame: Intraoperative status
Perioperative data
conversion rates to open surgery(%)
Time frame: Intraoperative status
Perioperative data
conversion rates to radical nephrectomy(%)
Time frame: Intraoperative status
Perioperative data
reoperation rate(%)
Time frame: Intraoperative status
Perioperative data
postoperative length of stay (day).
Time frame: Postoperative 30 days
postoperative data
postoperative estimated glomerular filtration rate(ml/min/1.73m2).
Time frame: Postoperative 3/30/60/90 days and 1/2/3 years
Incidence of postoperative complications
We will assess the complications by conducting telephone follow-up, as well as reviewing the results of postoperative radiological and laboratory tests. The complications included whether the patients experienced bleeding, infection, urinary fistula and renal insufficiency.
Time frame: Postoperative 3/30/60/90 days and 1/2/3 years
Tumour recurrence or metastasis
We will conduct telephone follow-up and review the results of postoperative radiological tests to see whether tumour recurrence or metastasis occurred.
Time frame: Postoperative 30/60/90 days and 1/2/3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.